Current opinion in HIV and AIDS

Keyphrases

Publications

volume 19, number 3, 2024

Eline Pellaers, Zeger Debyser
EDITORIAL: Putting HIV in the big sleep with the block-and-lock strategy. Current opinion in HIV and AIDS 19 (3) (2024)
Andrea Mastrangelo, Lucio Gama, Paola Cinque
Strategies to target the central nervous system HIV reservoir. Current opinion in HIV and AIDS 19 (3) (2024)
Vinita R Joshi, Marcus Altfeld
Harnessing natural killer cells to target HIV-1 persistence. Current opinion in HIV and AIDS 19 (3) (2024)
Eline Pellaers, Alexe Denis, Zeger Debyser
New latency-promoting agents for a block-and-lock functional cure strategy. Current opinion in HIV and AIDS 19 (3) (2024)
Eline Pellaers, Alexe Denis, Zeger Debyser
New latency-promoting agents for a block-and-lock functional cure strategy. Current opinion in HIV and AIDS 19 (3) (2024)
Rachel E Berman, Will Dampier, Michael R Nonnemacher, Brian Wigdahl
What's in a cure: designing a broad-spectrum HIV gene therapy. Current opinion in HIV and AIDS 19 (3) (2024)
Céline Fombellida-Lopez, Ben Berkhout, Gilles Darcis, Alexander O Pasternak
Persistent HIV-1 transcription during ART: time to reassess its significance? Current opinion in HIV and AIDS 19 (3) (2024)
Riddhima Banga, Matthieu Perreau
The multifaceted nature of HIV tissue reservoirs. Current opinion in HIV and AIDS 19 (3) (2024)
Moa F Hasler, Roberto F Speck, Nicole P Kadzioch
Humanized mice for studying HIV latency and potentially its eradication. Current opinion in HIV and AIDS 19 (3) (2024)
Céline Fombellida-Lopez, Ben Berkhout, Gilles Darcis, Alexander O Pasternak
Persistent HIV-1 transcription during ART: time to reassess its significance? Current opinion in HIV and AIDS 19 (3) (2024)
Benjamin Bone, Mathias Lichterfeld
"Block and lock" viral integration sites in persons with drug-free control of HIV-1 infection. Current opinion in HIV and AIDS 19 (3) (2024)
Eline Pellaers, Alexe Denis, Zeger Debyser
New latency-promoting agents for a block-and-lock functional cure strategy. Current opinion in HIV and AIDS 19 (3) (2024)
Céline Fombellida-Lopez, Ben Berkhout, Gilles Darcis, Alexander O Pasternak
Persistent HIV-1 transcription during ART: time to reassess its significance? Current opinion in HIV and AIDS 19 (3) (2024)
Andrea Mastrangelo, Lucio Gama, Paola Cinque
Strategies to target the central nervous system HIV reservoir. Current opinion in HIV and AIDS 19 (3) (2024)
Eline Pellaers, Zeger Debyser
EDITORIAL: Putting HIV in the big sleep with the block-and-lock strategy. Current opinion in HIV and AIDS 19 (3) (2024)
Kien Nguyen, Jonathan Karn
The sounds of silencing: dynamic epigenetic control of HIV latency. Current opinion in HIV and AIDS 19 (3) (2024)
Benjamin Bone, Mathias Lichterfeld
"Block and lock" viral integration sites in persons with drug-free control of HIV-1 infection. Current opinion in HIV and AIDS 19 (3) (2024)

volume 19, number 4, 2024

Jingjing Li, Yaxin Liu, Eric Nehl, Joseph D Tucker
A behavioral economics approach to enhancing HIV preexposure and postexposure prophylaxis implementation. Current opinion in HIV and AIDS 19 (4) (2024)
Amanda M Buck, Brian H LaFranchi, Timothy J Henrich
Gaining momentum: stem cell therapies for HIV cure. Current opinion in HIV and AIDS 19 (4) (2024)
Tehillah T Chinunga, Ann Chahroudi, Susan P Ribeiro
Pediatric immunotherapy and HIV control. Current opinion in HIV and AIDS 19 (4) (2024)
Jina Lee, James B Whitney
Immune checkpoint inhibition as a therapeutic strategy for HIV eradication: current insights and future directions. Current opinion in HIV and AIDS 19 (4) (2024)
Amanda M Buck, Brian H LaFranchi, Timothy J Henrich
Gaining momentum: stem cell therapies for HIV cure. Current opinion in HIV and AIDS 19 (4) (2024)
Hang Su, April Mueller, Harris Goldstein
Recent advances on anti-HIV chimeric antigen receptor-T-cell treatment to provide sustained HIV remission. Current opinion in HIV and AIDS 19 (4) (2024)
Tehillah T Chinunga, Ann Chahroudi, Susan P Ribeiro
Pediatric immunotherapy and HIV control. Current opinion in HIV and AIDS 19 (4) (2024)
Jina Lee, James B Whitney
Immune checkpoint inhibition as a therapeutic strategy for HIV eradication: current insights and future directions. Current opinion in HIV and AIDS 19 (4) (2024)
Amanda M Buck, Brian H LaFranchi, Timothy J Henrich
Gaining momentum: stem cell therapies for HIV cure. Current opinion in HIV and AIDS 19 (4) (2024)
Tehillah T Chinunga, Ann Chahroudi, Susan P Ribeiro
Pediatric immunotherapy and HIV control. Current opinion in HIV and AIDS 19 (4) (2024)
Fabrícia Heloisa Cavicchioli Sugiyama, Lisa Loksø Dietz, Ole Schmeltz Søgaard
Utilizing immunotherapy towards achieving a functional cure for HIV-1. Current opinion in HIV and AIDS 19 (4) (2024)
Fabrícia Heloisa Cavicchioli Sugiyama, Lisa Loksø Dietz, Ole Schmeltz Søgaard
Utilizing immunotherapy towards achieving a functional cure for HIV-1. Current opinion in HIV and AIDS 19 (4) (2024)
Amanda M Buck, Brian H LaFranchi, Timothy J Henrich
Gaining momentum: stem cell therapies for HIV cure. Current opinion in HIV and AIDS 19 (4) (2024)
Tehillah T Chinunga, Ann Chahroudi, Susan P Ribeiro
Pediatric immunotherapy and HIV control. Current opinion in HIV and AIDS 19 (4) (2024)
Amanda M Buck, Brian H LaFranchi, Timothy J Henrich
Gaining momentum: stem cell therapies for HIV cure. Current opinion in HIV and AIDS 19 (4) (2024)
Hang Su, April Mueller, Harris Goldstein
Recent advances on anti-HIV chimeric antigen receptor-T-cell treatment to provide sustained HIV remission. Current opinion in HIV and AIDS 19 (4) (2024)
Jingjing Li, Yaxin Liu, Eric Nehl, Joseph D Tucker
A behavioral economics approach to enhancing HIV preexposure and postexposure prophylaxis implementation. Current opinion in HIV and AIDS 19 (4) (2024)

volume 19, number 5, 2024

Sydney G Nelson, Cindy M Liu
Penile microbiome: decoding its impact on HIV risk. Current opinion in HIV and AIDS 19 (5) (2024)
Ricky A Lippincott, John O'Connor, Charles P Neff, Catherine Lozupone, Brent E Palmer
Deciphering HIV-associated inflammation: microbiome's influence and experimental insights. Current opinion in HIV and AIDS 19 (5) (2024)
Talía Sainz, Grace Aldrovandi
Pediatric perspective: the microbiome in vertical HIV-infection: unravelling gaps, challenges, and therapeutic potential. Current opinion in HIV and AIDS 19 (5) (2024)
Sydney G Nelson, Cindy M Liu
Penile microbiome: decoding its impact on HIV risk. Current opinion in HIV and AIDS 19 (5) (2024)
Ricky A Lippincott, John O'Connor, Charles P Neff, Catherine Lozupone, Brent E Palmer
Deciphering HIV-associated inflammation: microbiome's influence and experimental insights. Current opinion in HIV and AIDS 19 (5) (2024)
Alexandra M Ortiz, Jason M Brenchley
Untangling the role of the microbiome across the stages of HIV disease. Current opinion in HIV and AIDS 19 (5) (2024)
Ricky A Lippincott, John O'Connor, Charles P Neff, Catherine Lozupone, Brent E Palmer
Deciphering HIV-associated inflammation: microbiome's influence and experimental insights. Current opinion in HIV and AIDS 19 (5) (2024)
Xiangning Bai, Susanne Dam Nielsen, Ken M Kunisaki, Marius Trøseid
Pulmonary comorbidities in people with HIV- the microbiome connection. Current opinion in HIV and AIDS 19 (5) (2024)
Sydney G Nelson, Cindy M Liu
Penile microbiome: decoding its impact on HIV risk. Current opinion in HIV and AIDS 19 (5) (2024)
Emily M Cherenack, Courtney A Broedlow, Nichole R Klatt
The vaginal microbiome and HIV transmission dynamics. Current opinion in HIV and AIDS 19 (5) (2024)
Sydney G Nelson, Cindy M Liu
Penile microbiome: decoding its impact on HIV risk. Current opinion in HIV and AIDS 19 (5) (2024)
Xiangning Bai, Anders Sönnerborg, Piotr Nowak
Elite controllers microbiome: unraveling the mystery of association and causation. Current opinion in HIV and AIDS 19 (5) (2024)
Alexandra M Ortiz, Jason M Brenchley
Untangling the role of the microbiome across the stages of HIV disease. Current opinion in HIV and AIDS 19 (5) (2024)
Alexandra M Ortiz, Jason M Brenchley
Untangling the role of the microbiome across the stages of HIV disease. Current opinion in HIV and AIDS 19 (5) (2024)
Alexandra M Ortiz, Jason M Brenchley
Untangling the role of the microbiome across the stages of HIV disease. Current opinion in HIV and AIDS 19 (5) (2024)
Rene Bulnes, Netanya S Utay
Therapeutic microbiome modulation: new frontiers in HIV treatment. Current opinion in HIV and AIDS 19 (5) (2024)